HRS Co., Ltd (KOSDAQ:036640)
4,995.00
-105.00 (-2.06%)
At close: Feb 2, 2026
HRS Co., Ltd Revenue
HRS Co., Ltd had revenue of 20.78B KRW in the quarter ending September 30, 2025, with 10.05% growth. This brings the company's revenue in the last twelve months to 79.13B, down -1.52% year-over-year. In the year 2024, HRS Co., Ltd had annual revenue of 80.23B with 2.64% growth.
Revenue (ttm)
79.13B
Revenue Growth
-1.52%
P/S Ratio
1.03
Revenue / Employee
497.67M
Employees
159
Market Cap
81.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.23B | 2.07B | 2.64% |
| Dec 31, 2023 | 78.17B | -7.93B | -9.21% |
| Dec 31, 2022 | 86.10B | 2.03B | 2.42% |
| Dec 31, 2021 | 84.06B | 16.66B | 24.71% |
| Dec 31, 2020 | 67.41B | 685.33M | 1.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Creas F&C Co.,Ltd | 484.33B |
| FSN Co., Ltd. | 348.13B |
| APRO Co., Ltd | 209.33B |
| Jeil M&S | 202.36B |
| Icure Pharmaceutical Incorporation | 93.22B |
| M2N Co.,Ltd | 88.99B |
| WINPAC | 69.62B |
| HLB Genex | 40.95B |